Section

Divis Lab Q1 PAT climbs 21% YoY to Rs 430 cr

By Business Standard - 4 months ago
The pharma major's consolidated net profit jumped 20.79% to Rs 430 crore in Q1 FY25 as against Rs 356 crore recorded in Q1 FY24.

Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.